Skip to main content
. 2018 May 10;84(3):717–725. doi: 10.1093/neuros/nyy178

TABLE 4.

ARE in 371 Acromegaly Patients Treated With SRS

Variable Total (%)
New endocrinopathya 97 (26.1%)
 Hypothyroidism 62 (16.7%)
 Testosterone/Estrogen deficiency 49 (13.2%)
 Hypocortisolism 39 (10.5%)
New cranial neuropathyb 16 (4.3%)
 CN II 13 (3.5%)
 CN III 1 (0.3%)
 CN IV 1 (0.3%)
 CN V 3 (0.8%)
 CN VI 1 (0.3%)

CN, cranial nerve

a41 patients had multiple new endocrinopathies.

bTwo patients had multiple new cranial neuropathies.